ReviewMolecular biology reports2026
Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Among women worldwide, breast cancer (BC) is a prevalent and deadly form of cancer. Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) of BC, playing an indispensable role in the development and treatment of BC. Recent studies have shown that exosomes are important mediators of communication between tumor cells and TAMs. On the one hand, exosomes from tumor cells can regulate the function of TAMs. On the other hand, TAMs influence the pathogenesis, progression, and metastasis of BC by exosomes. Meanwhile, possible therapeutic options targeting exosomes between BC and TAMs, such as biomarkers, influencing the release and uptake of exosomes, and drug delivery systems, have become the frontiers of BC therapy. This review summarizes new developments in exosome-mediated communication between BC and TAMs. The focus is on the role and mechanism of exosomes. At the same time, we discuss possible therapeutic options for targeting exosomes between BC and TAMs to provide new ideas for the treatment of BC.
Indexed as
Identifiers
41557096What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.